Simon Barnett (@simondbarnett) 's Twitter Profile
Simon Barnett

@simondbarnett

Head of Research (@_DimensionCap) // Interested in all things Bio x Compute // Previous biotech public equity investor + Chemical Engineer (@JHU_ChemBE)

ID: 1665395234442821633

linkhttps://research.dimensioncap.com/ calendar_today04-06-2023 16:29:20

484 Tweet

2,2K Followers

1,1K Following

Simon Barnett (@simondbarnett) 's Twitter Profile Photo

I thought this was one of the most provocative images from the EVOLVEpro paper by Omar Abudayyeh and Jonathan Gootenberg. Supported by experimental data, they assert that a protein's fitness and its activity are lowly, or even negatively, correlated. How could this be? Shouldn't nature

I thought this was one of the most provocative images from the EVOLVEpro paper by <a href="/omarabudayyeh/">Omar Abudayyeh</a> and <a href="/jgooten/">Jonathan Gootenberg</a>.

Supported by experimental data, they assert that a protein's fitness and its activity are lowly, or even negatively, correlated. How could this be?

Shouldn't nature
Simon Barnett (@simondbarnett) 's Twitter Profile Photo

As small molecule drugs become larger, biologics become smaller, and peptide therapeutics gain adoption, how will it act as a forcing function for new representations in ML applied to molecular design? Do we default to atoms/electrons vis-a-vis neural network potentials? Does

As small molecule drugs become larger, biologics become smaller, and peptide therapeutics gain adoption, how will it act as a forcing function for new representations in ML applied to molecular design?

Do we default to atoms/electrons vis-a-vis neural network potentials?

Does
Brandon White (@bwhite5290) 's Twitter Profile Photo

The sweet spot is going to be bigger small molecules (macrocycles, protocs, etc) and smaller peptides (glp1, etc). Drug discovery is going to experience a renaissance here. The training data is there, the therapeutic benefit is there, and the cost/supply is there. Underhyped.

Simon Barnett (@simondbarnett) 's Twitter Profile Photo

There are over 500 amino acids. Also known as non-standard, non-canonical, or even unnatural, these amino acids have diverse functions in Nature and appear to be imbuing therapies with superior physiochemical properties. Read more in my newest essay. tinyurl.com/3apurs2r

There are over 500 amino acids. 

Also known as non-standard, non-canonical, or even unnatural, these amino acids have diverse functions in Nature and appear to be imbuing therapies with superior physiochemical properties. 

Read more in my newest essay.

tinyurl.com/3apurs2r
Eric Dai (@ericdai_bioe) 's Twitter Profile Photo

Peptide- and protein-based biologics like incretin mimetics and antibody drug conjugates constitute a massive and rapidly growing class of drugs. Unnatural Amino Acids are a burgeoning lever to engineer drug-like properties (e.g., site specific conjugation, proteolytic

Zavain Dar (@zavaindar) 's Twitter Profile Photo

Today we’re launching Chai Discovery, led by Joshua Meier & his polymathic world class cofounders. We’re also open sourcing Chai-1: a state of the art frontier model for biomolecular interactions. DIMENSION has co-led the founding round alongside Thrive & OpenAI

Today we’re launching <a href="/chaidiscovery/">Chai Discovery</a>, led by <a href="/joshim5/">Joshua Meier</a> &amp; his polymathic world class cofounders. We’re also open sourcing Chai-1: a state of the art frontier model for biomolecular interactions. <a href="/_DimensionCap/">DIMENSION</a> has co-led the founding round alongside Thrive &amp; OpenAI
Simon Barnett (@simondbarnett) 's Twitter Profile Photo

Since meeting Joshua Meier Jack Dent and the entire Chai team, I've been inspired by their creativity and tenacity. While I'll miss my temporary desk-mates at the DIMENSION offices, I'm ecstatic to see these folks get Chai-1 out in the open -- the first of many!

Charlie Harris (@charlieharris01) 's Twitter Profile Photo

Confused by the number of open-sourced AlphaFold3 alternatives recently put out on the market? So was I - so I wrote a little thing about it! Link below 👇

Confused by the number of open-sourced AlphaFold3 alternatives recently put out on the market?

So was I - so I wrote a little thing about it!

Link below 👇
Robert Y. Chen (@therealryc) 's Twitter Profile Photo

Really fantastic article demystifying how cryptic pocket search can be enabled by clever computational tricks, including “defying gravity” Simon Barnett breaks it down

Simon Barnett (@simondbarnett) 's Twitter Profile Photo

I'm excited to be speaking about the business landscape behind ML in drug discovery & development at the inaugural State of AI in Drug Discovery summit hosted by Genetic Engineering & Biotechnology News on October 30th! Register Now: webinars.liebertpub.com/e/The-State-of…